JG
VIVO

Jefferies Group’s Meridian Bioscience Inc VIVO Stock Holding History

Jefferies Group’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,539
Closed -$217K – 2709
2018
Q3 		$217K Buy
+14,539
New +$225K ﹤0.01% 2069
2018
Q2 		– Sell
-42,329
Closed -$601K – 2787
2018
Q1 		$601K Buy
+42,329
New +$626K ﹤0.01% 1410
2017
Q2 		– Sell
-13,020
Closed -$180K – 2677
2017
Q1 		$180K Sell
13,020
-1,338
-9% -$18.7K ﹤0.01% 2048
2016
Q4 		$254K Buy
+14,358
New +$252K ﹤0.01% 1826
2016
Q3 		– Sell
-11,145
Closed -$217K – 2525
2016
Q2 		$217K Buy
+11,145
New +$219K ﹤0.01% 1790
2015
Q3 		– Sell
-2,722
Closed -$51K – 3244
2015
Q2 		$51K Buy
+2,722
New +$50.5K ﹤0.01% 2429

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Jefferies Group's VIVO Position: Q4 2018 in Review

Jefferies Group sold out of Meridian Bioscience Inc (VIVO) in Q4 2018, closing a stake of 14,539 shares — an estimated $217K sold.

Jefferies Group first reported a position in VIVO in Q2 2015 and held it in 6 quarters. The position peaked at $601K in Q1 2018. 191 funds tracked by Wall St. Rank hold VIVO as of Q4 2018.

  • Jefferies Group reported no remaining Meridian Bioscience Inc position as of Q4 2018 after selling out during the quarter.
  • Jefferies Group sold 14,539 Meridian Bioscience Inc shares in Q4 2018, an estimated $217K.
  • Jefferies Group first reported a position in Meridian Bioscience Inc in Q2 2015 and held it in 6 quarters.
  • Jefferies Group's Meridian Bioscience Inc position peaked at $601K in Q1 2018.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2018.

Based on Jefferies Group's 13F filing for Q4 2018, filed 14 Feb 2019.